Overweight in liver transplant recipients
- PMID: 24573630
- DOI: 10.1590/s0100-69912013000600014
Overweight in liver transplant recipients
Abstract
This review aims to describe the incidence and prevalence of overweight and obesity after liver transplantation and the consequences associated with it. Literature review consultation was conducted in Medline / PubMed, SciELO, EMBASE and LILACS, with the combination of the following keywords: liver transplantation, overweight, obesity, weight gain. Overweight is incident on more than 60% of patients undergoing liver transplantation and obesity rates exceed 20% in the first year after surgery, during which occurs the largest relative weight gain. Studies have shown that between 60% and 70% of patients undergoing liver transplantation are overweight after the third year, 90% with abdominal obesity. Associated factors are, among others, advanced age, family history of overweight and excess weight prior to liver disease. The contribution of immunosuppressive medication remains controversial. Some of the consequences of overweight are liver steatosis, steatohepatitis, diabetes mellitus, hypertension, dyslipidemia, cardiovascular disease and death.
Similar articles
-
Weight Gain Trajectory Predicts Long-term Overweight and Obesity After Pediatric Liver Transplant.J Pediatr Gastroenterol Nutr. 2019 Jan;68(1):89-95. doi: 10.1097/MPG.0000000000002127. J Pediatr Gastroenterol Nutr. 2019. PMID: 30119101 Free PMC article.
-
Overweight, obesity and weight gain up to three years after liver transplantation.Nutr Hosp. 2012 Jul-Aug;27(4):1351-6. doi: 10.3305/nh.2012.27.4.5768. Nutr Hosp. 2012. PMID: 23165585
-
Weight gain, overweight and obesity in solid organ transplantation--a study protocol for a systematic literature review.Syst Rev. 2015 Jan 6;4(1):2. doi: 10.1186/2046-4053-4-2. Syst Rev. 2015. PMID: 25563983 Free PMC article.
-
Long-term management of the liver transplant patient: diabetes, hyperlipidemia, and obesity.Liver Transpl. 2001 Nov;7(11 Suppl 1):S13-21. doi: 10.1053/jlts.2001.29167. Liver Transpl. 2001. PMID: 11689772 Review.
-
Metabolic syndrome and its components after liver transplantation: incidence, prevalence, risk factors, and implications.Clin Nutr. 2010 Apr;29(2):175-9. doi: 10.1016/j.clnu.2009.08.008. Epub 2009 Sep 23. Clin Nutr. 2010. PMID: 19783330 Review.
Cited by
-
Extrahepatic organs in the development of non-alcoholic fatty liver disease in liver transplant patients.Hepatobiliary Surg Nutr. 2022 Jun;11(3):400-411. doi: 10.21037/hbsn-20-568. Hepatobiliary Surg Nutr. 2022. PMID: 35693397 Free PMC article. Review.
-
DO THE IMMUNOSUPPRESSIVE DRUGS AFFECT THE HYPOTHALAMIC NUCLEI INVOLVED IN THE REGULATION OF FOOD INTAKE? AN EXPERIMENTAL STUDY.Arq Bras Cir Dig. 2022 Jan 31;34(4):e1636. doi: 10.1590/0102-672020210002e1636. eCollection 2022. Arq Bras Cir Dig. 2022. PMID: 35107498 Free PMC article.
-
SARCOPENIA, OBESITY AND SARCOPENIC OBESITY IN LIVER TRANSPLANTATION: A BODY COMPOSITION PROSPECTIVE STUDY.Arq Bras Cir Dig. 2019;32(2):e1434. doi: 10.1590/0102-672020190001e1434. Epub 2019 Apr 29. Arq Bras Cir Dig. 2019. PMID: 31038559 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical